S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
3 reasons to buy AMD before 2024
How does the Consumer Price Index affect the stock market?
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Generative AI boosts UiPath; analysts see triple-digit EPS growth
New CBOE “special perk” helps traders target income every weekend (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
3 reasons to buy AMD before 2024
How does the Consumer Price Index affect the stock market?
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Generative AI boosts UiPath; analysts see triple-digit EPS growth
New CBOE “special perk” helps traders target income every weekend (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
3 reasons to buy AMD before 2024
How does the Consumer Price Index affect the stock market?
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Generative AI boosts UiPath; analysts see triple-digit EPS growth
New CBOE “special perk” helps traders target income every weekend (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
3 reasons to buy AMD before 2024
How does the Consumer Price Index affect the stock market?
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Generative AI boosts UiPath; analysts see triple-digit EPS growth
New CBOE “special perk” helps traders target income every weekend (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 

Privia Health Group Stock Price, News & Analysis (NASDAQ:PRVA)

$21.23
+0.13 (+0.62%)
(As of 12/8/2023 ET)
Compare
Today's Range
$20.87
$21.37
50-Day Range
$20.42
$23.65
52-Week Range
$19.68
$30.15
Volume
380,857 shs
Average Volume
626,078 shs
Market Capitalization
$2.51 billion
P/E Ratio
68.48
Dividend Yield
N/A
Price Target
$34.55

Privia Health Group MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
62.7% Upside
$34.55 Price Target
Short Interest
Bearish
6.63% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.18mentions of Privia Health Group in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$454,370 Sold Last Quarter
Proj. Earnings Growth
45.45%
From $0.22 to $0.32 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.82 out of 5 stars

Medical Sector

58th out of 954 stocks

Health Services Industry

2nd out of 12 stocks


PRVA stock logo

About Privia Health Group Stock (NASDAQ:PRVA)

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. is a subsidiary of Brighton Health Group Holdings, LLC.

PRVA Stock Price History

PRVA Stock News Headlines

Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Privia Health Group Inc PRVA
Privia Health Group Inc
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Q3 2023 Privia Health Group Inc Earnings Call
Privia Health (PRVA) Q3 Earnings Miss Estimates
4 Analysts Have This to Say About Privia Health Gr
See More Headlines
Receive PRVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/03/2023
Today
12/09/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/27/2024

Industry, Sector and Symbol

Industry
Health services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PRVA
Fax
N/A
Employees
964
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$34.55
High Stock Price Target
$41.00
Low Stock Price Target
$26.00
Potential Upside/Downside
+62.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
9 Analysts

Profitability

Net Income
$-8,590,000.00
Pretax Margin
1.78%

Debt

Sales & Book Value

Annual Sales
$1.36 billion
Book Value
$4.53 per share

Miscellaneous

Free Float
50,059,000
Market Cap
$2.51 billion
Optionable
Not Optionable
Beta
0.78
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report














PRVA Stock Analysis - Frequently Asked Questions

Should I buy or sell Privia Health Group stock right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Privia Health Group in the last twelve months. There are currently 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" PRVA shares.
View PRVA analyst ratings
or view top-rated stocks.

What is Privia Health Group's stock price target for 2024?

9 brokers have issued 1-year target prices for Privia Health Group's stock. Their PRVA share price targets range from $26.00 to $41.00. On average, they predict the company's stock price to reach $34.55 in the next year. This suggests a possible upside of 62.7% from the stock's current price.
View analysts price targets for PRVA
or view top-rated stocks among Wall Street analysts.

How have PRVA shares performed in 2023?

Privia Health Group's stock was trading at $22.71 at the beginning of 2023. Since then, PRVA shares have decreased by 6.5% and is now trading at $21.23.
View the best growth stocks for 2023 here
.

When is Privia Health Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024.
View our PRVA earnings forecast
.

How were Privia Health Group's earnings last quarter?

Privia Health Group, Inc. (NASDAQ:PRVA) issued its quarterly earnings data on Friday, November, 3rd. The company reported $0.05 earnings per share for the quarter, hitting the consensus estimate of $0.05. The business earned $417.30 million during the quarter, compared to analysts' expectations of $410.51 million. Privia Health Group had a trailing twelve-month return on equity of 6.80% and a net margin of 2.40%. The business's revenue was up 21.7% on a year-over-year basis. During the same period in the previous year, the business posted $0.01 earnings per share.

When did Privia Health Group IPO?

(PRVA) raised $351 million in an initial public offering on Thursday, April 29th 2021. The company issued 19,500,000 shares at a price of $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair acted as the underwriters for the IPO and Canaccord Genuity, Truist Securities, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

Who are Privia Health Group's major shareholders?

Privia Health Group's stock is owned by many different retail and institutional investors. Top institutional shareholders include FMR LLC (12.09%), Wellington Management Group LLP (3.94%), Bank of New York Mellon Corp (3.44%), Riverbridge Partners LLC (3.40%), Principal Financial Group Inc. (2.99%) and Invesco Ltd. (1.46%). Insiders that own company stock include Advisors LLC Mbd, David Mountcastle, Jeffrey B Butler, Jeffrey Daniel Bernstein, Matthew Shawn Morris, Pamplona Capital Partners Iii,, Parth Mehrotra, Thomas Bartrum and William M Sullivan.
View institutional ownership trends
.

How do I buy shares of Privia Health Group?

Shares of PRVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:PRVA) was last updated on 12/9/2023 by MarketBeat.com Staff

My Account -